BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 10202051)

  • 1. Mutations that cause the Wiskott-Aldrich syndrome impair the interaction of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein.
    Stewart DM; Tian L; Nelson DL
    J Immunol; 1999 Apr; 162(8):5019-24. PubMed ID: 10202051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Wiskott-Aldrich syndrome (WAS) mutants using Saccharomyces cerevisiae.
    Rajmohan R; Raodah A; Wong MH; Thanabalu T
    FEMS Yeast Res; 2009 Dec; 9(8):1226-35. PubMed ID: 19817875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wiskott-Aldrich syndrome (role of WASP).
    Nonoyama S
    J Med Dent Sci; 2001 Mar; 48(1):1-6. PubMed ID: 12160237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WASP suppresses the growth defect of Saccharomyces cerevisiae las17Delta strain in the presence of WIP.
    Rajmohan R; Meng L; Yu S; Thanabalu T
    Biochem Biophys Res Commun; 2006 Apr; 342(2):529-36. PubMed ID: 16488394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two novel mutations of Wiskott-Aldrich syndrome: the molecular prediction of interaction between the mutated WASP L101P with WASP-interacting protein by molecular modeling.
    Kim MK; Kim ES; Kim DS; Choi IH; Moon T; Yoon CN; Shin JS
    Biochim Biophys Acta; 2004 Oct; 1690(2):134-40. PubMed ID: 15469902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of the WASP gene in 10 Japanese patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
    Itoh S; Nonoyama S; Morio T; Imai K; Okawa H; Ochs HD; Shimadzu M; Yata J
    Int J Hematol; 2000 Jan; 71(1):79-83. PubMed ID: 10729999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the expression of the Wiskott-Aldrich syndrome protein.
    Stewart DM; Treiber-Held S; Kurman CC; Facchetti F; Notarangelo LD; Nelson DL
    J Clin Invest; 1996 Jun; 97(11):2627-34. PubMed ID: 8647957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A second-site mutation in the initiation codon of WAS (WASP) results in expansion of subsets of lymphocytes in an Wiskott-Aldrich syndrome patient.
    Du W; Kumaki S; Uchiyama T; Yachie A; Yeng Looi C; Kawai S; Minegishi M; Ramesh N; Geha RS; Sasahara Y; Tsuchiya S
    Hum Mutat; 2006 Apr; 27(4):370-5. PubMed ID: 16511828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of six novel WASP gene mutations in patients suffering from Wiskott-Aldrich syndrome.
    Brooimans RA; van den Berg AJ; Tamminga RY; Revesz T; Wulffraat NM; Zegers BJ
    Hum Mutat; 2000 Apr; 15(4):386-7. PubMed ID: 10737997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A complex of N-WASP and WIP integrates signalling cascades that lead to actin polymerization.
    Moreau V; Frischknecht F; Reckmann I; Vincentelli R; Rabut G; Stewart D; Way M
    Nat Cell Biol; 2000 Jul; 2(7):441-8. PubMed ID: 10878810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two novel mutations identified in the Wiskott-Aldrich syndrome protein gene cause Wiskott-Aldrich syndrome and thrombocytopenia.
    Andreu N; Matamoros N; Escudero A; Fillat C
    Int J Mol Med; 2007 May; 19(5):777-82. PubMed ID: 17390083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mutations in the Wiskott-Aldrich syndrome protein gene and their effects on transcriptional, translational, and clinical phenotypes.
    Lemahieu V; Gastier JM; Francke U
    Hum Mutat; 1999; 14(1):54-66. PubMed ID: 10447259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective actin polymerization in EBV-transformed B-cell lines from patients with the Wiskott-Aldrich syndrome.
    Facchetti F; Blanzuoli L; Vermi W; Notarangelo LD; Giliani S; Fiorini M; Fasth A; Stewart DM; Nelson DL
    J Pathol; 1998 May; 185(1):99-107. PubMed ID: 9713366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor.
    Tardif M; Brouchon L; Rabiet MJ; Boulay F
    Biochem J; 2003 Jun; 372(Pt 2):453-63. PubMed ID: 12600272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WIP, a protein associated with wiskott-aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells.
    Ramesh N; Antón IM; Hartwig JH; Geha RS
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14671-6. PubMed ID: 9405671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of WASP mutations in 10 Australian families with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
    Bourne HC; Weston S; Prasad M; Edkins E; Benson EM
    Pathology; 2004 Jun; 36(3):262-4. PubMed ID: 15203732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WIP null mice display a progressive immunological disorder that resembles Wiskott-Aldrich syndrome.
    Curcio C; Pannellini T; Lanzardo S; Forni G; Musiani P; Antón IM
    J Pathol; 2007 Jan; 211(1):67-75. PubMed ID: 17086554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular biology of the Wiskott-Aldrich syndrome.
    Rengan R; Ochs HD
    Rev Immunogenet; 2000; 2(2):243-55. PubMed ID: 11258421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting edge: WIP, a binding partner for Wiskott-Aldrich syndrome protein, cooperates with Vav in the regulation of T cell activation.
    Savoy DN; Billadeau DD; Leibson PJ
    J Immunol; 2000 Mar; 164(6):2866-70. PubMed ID: 10706671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Wiskott-Aldrich syndrome.
    Ochs HD
    Semin Hematol; 1998 Oct; 35(4):332-45. PubMed ID: 9801262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.